Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
G20 engagement We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
Commitment tracker An open platform for the global health community to share and track commitments that will support Member States in implementing the WHA Resolution on diagnostics.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease.
Dr Jutta Reinhard-Rupp, serving as FIND interim CEO The FIND Board of Directors has announced that Dr Jutta Reinhard-Rupp, currently FIND Chief Scientific Officer, will serve as interim Chief Executive Officer, with immediate effect following Dr Ifedayo Adetifa’s departure
DxConnect DxConnect is hosted by FIND, to overcome diagnostic gaps by connecting stakeholders and enabling interactions.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
WHA Resolution on strengthening diagnostics capacity The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Dr Jutta Reinhard-Rupp, serving as FIND interim CEO The FIND Board of Directors has announced that Dr Jutta Reinhard-Rupp, currently FIND Chief Scientific Officer, will serve as interim Chief Executive Officer, with immediate effect following Dr Ifedayo Adetifa’s departure 22 May 2026
Mr Taihitu P. Bonanza joins FIND’s Board, strengthening global leadership for equitable access to diagnostics 13 May 2026
FIND Board Chair Dr Ayoade Alakija recognised among Top 20 Leaders Shaping Health Across Africa 15 Apr 2026
Advancing Schistosomiasis Control: The Quest for Improved Diagnostics Sarah Hingel, Erik Coumou 29 Jan 2026
Dr. Ifedayo Adetifa on NTDs, Cervical Cancer & Africa’s Pandemic Preparedness Adonis Byemelwa 17 Feb 2025
Diagnostics & the Nagoya Protocol The Nagoya protocol is an international agreement, supplementary to the United Nations Convention on Biological Diversity.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease or infection in a defined geographic area, as a result of deliberate efforts.
Diagnostics & trade finance Trade finance is a term that describes the financial instruments and products used by companies to facilitate international trade and commerce.
Diagnostics & intellectual property The pharmaceutical and vaccine industries both make regular use of patents to protect their innovative products. The situation for diagnostics is less straightforward; in many cases, patents are less consequential for diagnostics than for other health products.
Diagnostics & vaccines The benefits of vaccines are well known. However, vaccines cannot be developed, tested, targeted, or used efficiently and effectively without diagnostics. This document explains how diagnostics are a critical enabler for vaccines.
